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and over 300,000 deaths per year in Nigeria 
(Salihu and Sanni, 2013). Malaria is still Afri-
ca’s leading health problem due to drug re-
sistance to most anti-malaria drugs, insecti-
cide resistance in mosquitoes, war and civil 
disturbances, environmental changes, climat-
ic changes, travel and population increase 
(WHO, 2008). 
ABSTRACT 
Garcinia kola stem bark forms part of recipes used traditionally for the treatment of malaria. In view of 
the prevalence of malaria in Nigeria, this study investigated the phytochemical, mineral and proximate 
components, as well as antiplasmodial activity and toxicological effect of Garcinia kola stem bark ex-
tract against Plasmodium berghei infected mice. The plant sample was screened for phytochemical, 
mineral and proximate components using standard laboratory techniques. Thirty five mice were divid-
ed into seven groups of five mice each. Malaria was induced in all the groups intraperitoneally with 0.2 
mL of infected blood containing about 107 of P. berghei parasitized red blood cells, except group 6 
(extract only) and group 7 (normal control). Group 1 received 100 mg/kg bodyweight of the extract 
orally. Group 2 received 200 mg/kg of the extract. Group 3 received 300 mg/kg of the extract. Group 4 
received 5 mg/kg of chloroquine. Group 5 (induced but untreated control). The haematology, liver 
function enzymes and histopathology of the liver were carried out using standard protocols.  The plant 
was rich in alkaloids, iron and fibre. The extract treated groups (1-3) showed significant decrease 
(p≤0.05) in parasitemia level after seven days of treatment. There was no significant difference in 
AST, ALT, ALP, bilirubin and GGT activities in all the extract treated groups compared to the control. 
No pathological changes were evident in histopathology of all the groups treated with various concen-
tration of the extract. The result obtained from this study confirmed the antiplasmodial activity of meth-
anol extract of G. kola stem bark. The highest inhibition of P. berghie parasite was observed at dose 
300 mg/kg comparable to chloroquine, with no hepatoxicity which confirmed the safety of G. kola. The 
phytochemicals and nutritional components could be responsible for the observed antiplasmodial ac-
tivity of the plant.  
 




Malaria is undoubtedly one of the world’s 
most deadly diseases (Winter et al., 2006). It 
is a major public health problem in Nigeria 
where it accounts for more death cases than 
any other country in the world. In Nigeria, 
97% of its population is at risk of malaria 
with an estimated 100 million malaria cases 
113 
Journal of Natural  
Science, Engineering 
and Technology  
ISSN: 
Print    -  2277 - 0593 
Online -  2315 - 7461 
© FUNAAB 2019 
J. Nat. Sci. Engr. & Tech. 2019, 18(1&2): 113-127 
 I. T. GBADAMOSI, A. O. ADEYI AND M. O. BRAIMOH  
Malaria is one of the major tropical parasitic 
diseases responsible for significant morbidi-
ty and mortality especially among children 
and pregnant women (Ekeanyanwu and 
Ogu, 2010). Malaria parasites belong to the 
genus Plasmodium (phylum Apicomplexa). 
In humans, malaria is caused by P. falcipa-
rum, P. maglariae, P. ovale, P. vivax and P. 
knowlesi (Mueller et al., 2007). Severe malaria 
is usually caused by P. falciparum (often re-
ferred to as falciparum malaria).  
 
Malaria is transmitted to humans via the 
bite of an infected female Anopheles mosqui-
to. Only female mosquitoes feed on blood; 
male mosquitoes feed on plant nectar, and 
thus do not transmit the disease. The fe-
males of the Anopheles genus of mosquito 
prefer to feed at night. They usually start 
searching for a meal at dusk, and will con-
tinue throughout the night until taking a 
meal (Arrow et al., 2004). The signs and 
symptoms of malaria typically begin 8-25 
days following infection (Bartoloni and 
Zammarchi, 2012; Fairhurst and Wellems, 
2010). The classic symptom of malaria is 
paroxysm, a cyclical occurrence of sudden 
coldness followed by rigor and then fever 
and sweating, occurring every two days 
(tertian fever) in P. vivax and P. ovale infec-
tions, and every three days (quartan fever) 
for P. malariae. P. falciparum infection can 
cause recurrent fever every 36–48 hours or 
a less pronounced and almost continuous 
fever (Ferri, 2009). 
 
Drugs used in the treatment of malaria are, 
chloroquine, mefloquine, artesunate, arte-
mether and bulaquine and their side effects 
include, vision impairment, deafness, loss of 
appetite, nausea, vomiting, diarrhoea, ab-
dominal cramps, skin eruptions, pigmenta-
tion, itching, sensitivity to light, hair loss, 
anaemia, reversible decrease in white blood 
cells and platelets, headache, depression and 
low blood pressure. Other side effects are 
dizziness, muscle pain, fever, headache, 
chills, skin rash, fatigue, circulatory disturb-
ances, chest pain, fast heart rate, rash, hives, 
and slow heart rate (Winstanley et al., 2004). 
Currently, multi-drug resistance has become 
one of the most important problems imped-
ing malaria control efforts (Sendagire et al., 
2005; Htut and Engl, 2009). In the late 
1940s, chloroquine was massively used and 
accepted worldwide, but resistance has 
spread to the vast majority of the malaria 
endemic regions like Africa, South East Asia 
and East Asia (Sanket and Sarita, 2009). Re-
sistance to mefloquine has become an issue 
in Combodia, Myanmar, and some border 
areas of Thailand. Although quinine and tet-
racycline are used in combination for treat-
ing uncomplicated malaria in some areas like 
Brazil and South East Asia, sensitivity to qui-
nine is still seriously diminishing (Fidock et 
al., 2004). Hence, the problem of resistance 
of plasmodium to antimalarial drugs in the 
malaria endemic regions of the world has left 
this region with an unprecedented situation 
in which the few and affordable treatment 
options are rapidly losing therapeutic efficacy 
(Khozirah et al., 2011). Spread of multidrug-
resistant strains of plasmodium and the ad-
verse side effects of the existing anti-malarial 
drugs have necessitated the search for novel, 
well tolerated and more efficient antimalarial 
drugs (Bickii et al., 2000). 
 
In Africa up to 80 % of the population still 
rely on herbal medicine to treat malaria and 
other diseases (Agbedahunsi, 2000), because 
of their affordability and accessibility. Al-
stonia boonei bark or leaves are administered 
as decoction (Majekodunmi et al., 2008).  
Most anti-malarial plants are used in form of 
monotherapy, and only a few plants are tak-
en together in combined therapies. An exam-
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ple is the multi-herbal antimalaria remedy 
that includes Cajanus cajan leaf, Euphorbia 
lateriflora leaf, Mangifera indica leaf and bark, 
Cassa alata leaf, Cymbopogon gigateus leaf, Nau-
clea latifolia leaf, and Uvaria chamae bark 
(Nwabuisi, 2002). Garcinia kola has many 
therapeutic values in Nigeria. It is used for 
the treatment of bronchitis, throat infec-
tions, and as an aphrodisiac, antioxidant, 
hypoglycaemic, antipurgative and antipara-
sitic, anticandidal and antimalarial agent 
(Gbadamosi et al., 2011; Ekene and Erhir-
hie, 2014).   
 
In view of the prevalence of malaria in Ni-
geria and the traditional use of Garcinia kola 
stem bark as antimalaria herb, this study 
investigated the phytochemical, mineral and 
proximate components of the plant, as well 
as its in vivo antiplasmodial activity in mice. 
This was done with a view to providing sci-
entific information on its efficacy as an anti-
malaria remedy. 
 
MATERIALS AND METHOD 
Collection, Identification and Prepara-
tion of Plant material 
Garcinia kola was collected from  the cam-
pus of the University of Ibadan. and identi-
fied at University of Ibadan Herbarium 
(UIH). The stem bark of the plant was 
washed, cut into small pieces and air dried 
at room temperature for two weeks and 
grounded to powder using electric blender. 
The powdered sample was put in an air-




Phytochemical, Mineral and Proximate 
Analyses 
The powdered plant sample was screened 
for the presence of alkaloids, saponins, tan-
nins, phenols, glycosides, philobatannins 
and anthraquinones (Wolfe et al., 2003; Har-
borne, 2005). The plant sample was digested 
prior to mineral analysis (Walsh, 1971). The 
sodium (Na), potassium (K), calcium (Ca), 
magnesium (Mg), zinc (Zn), copper (Cu) and 
iron (Fe) contents were determined using 
atomic absorption spectrophotometer. Phos-
phorus (P) was analysed using vanadolybdate 
method and the absorbance was read at 400 
nm (AOAC, 2005). The ash, crude fat, crude 
fibre, crude protein and moisture contents of 
the plant sample were analysed in the Labor-
atory of the Department of Animal Science, 
University of Ibadan, Nigeria (ASEAN, 
2011). 
 
Experimental Animals  
Thirty five male Swiss albino mice (20-30 g) 
used for the experiments were obtained from 
the Department of Pharmacognosy Animal 
House, University of Ibadan, Nigeria. The 
animals were fed with standard feed and had 
free access to water. They were also main-
tained under standard conditions of humidi-
ty, temperature and 12h light/darkness cycle. 
The animals were acclimatized for two weeks 
before the commencement of the study. The 
experiment was conducted in accordance 
with the guidelines for the care and use of 
laboratory animals (NIH, 2002). 
 
Maintenance and Estimation of plasmo-
dium parasite in experimental animals 
Plasmodium bergheii (NK-65) strain was ob-
tained from the Department of Biochemis-
try, Nigerian Institute of Medical Research 
(NIMR), Yaba, Lagos. The P. berghei was sub-
sequently maintained in the laboratory by 
serial blood passage from mice to mice every 
5-7 days. Three animals at a time were used 
as infected donors and as parasite reservoir. 
The donor mice were monitored for signs of 
infection which include lethargy, anorexia, 
ruffled appearance, shivering and heat-
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seeking behavior. Blood was taken from a 
donor mice previously infected with P. 
berghie (NK-65) and diluted with normal sa-
line. The percentage parasitemia and red 
blood cell count were determined. The par-
asitemia was estimated by examination of a 
well stained blood film. This was then ac-
complished by counting the number of par-
asitized red blood cells (pRBC) seen in 104 
red blood cells (equal to approximately 40 
monolayer cell fields of a standard micro-
scope using x100 oil immersion objective 
lens, each field containing  approximately 
250 RBCs). The number of pRBC was then 
divided by 100 to express it as a percentage 
(Moody, 2002). 
 
Inoculation of Animal with parasite 
Each mouse in the infected groups was in-
oculated intraperitoneally with 0.2 mL of 
infected blood containing about 1x107 of P. 
berghei parasitized red blood cells using a 
1mL syringe. Blood smear was prepared, 
stained, and observed under the microscope 
to establish parasitemia on the fifth day af-
ter inoculation. 
 
Preparation of methanol extract of sam-
ple and Chloroquine Phosphate 
Extracts were prepared by maceration of 
the powdered plant material with methanol; 
The powdered sample (750 g) was macer-
ated with 2.5 L of 50 % methanol for 24 
hours. After stirring for 3 hours, the metha-
nol was separated by filtration and then 
maceration was repeated three times on the 
residue. The three macerates were pooled 
and concentrated by a rotary evaporator at 
30oC to obtain a 60 g of methanol extract. 
The extract was kept in a tightly closed bot-
tle in a refrigerator for further use. The ex-
tracts were prepared into 100, 200 and 300 
mg/kg concentrations that were used for 
the antiplasmodial activity in mice. Two 
tablets each containing 250 mg chloroquine 
phosphate equivalent to 150 mg chloroquine 
base were dissolved in 50 mL distilled water 
and the resulting solution was shaken until a 
homogeneous solution was obtained. The 
animals were given 40 µL of the solution 
which is equivalent to 5 mg/kg body weight. 
The extract and standard drug were adminis-
tered into the experimental mice orally dur-
ing the experiment. 
 
Experimental Set-up 
The animals were divided into seven groups 
and each group consisted of 5 mice, the 
groups were treated as follows: 
Group 1 (G1):  They were infected with P. 
berghei and treated with 
100mg/kg of G. kola stem 
bark. 
Group 2 (G2):  They were the P. berghei in-
fected group treated with 
200mg/kg of G. kola stem 
bark. 
Group 3 (G3):  They were the P. berghei in-
fected group treated with 
300mg/kg of G. kola stem 
bark. 
Group 4 (G4):  They were the P. berghei in-
fected group treated with 
5mg/kg of chloroquine. 
Group 5 (G5):  They were the P. berghei in-
fected but not treated they 
were given access to normal 
feed and water. 
Group 6 (G6):  They were not infected with 
P. berghei but were given 
200mg/kg of G. Kola, which 
served as the extract control 
group. 
Group 7 (G7):  The control group that were 
neither infected nor treated 
throughout the experiment 
but were given free access to 
feed and water. 
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Estimation of parasitemia  
A drop of tail blood was collected from the 
mice into microscopic slides. A glass 
spreader was then used to spread the blood 
into a thin film. The spreader was drawn 
back to touch the drop of blood and the 
blood was allowed to extend along the edge 
of the spreader. Holding the spreader at 
about 300, the drop of blood was spread to 
make a film of about 40-50 mm in length 
(two-third of the slide) (Cheesbrough, 
1998). The film was allowed to dry, and 
then fixed with absolute methanol. The 
fixed film was then air dried and stained 
with 10% Giemsa stain at pH 7.2 for about 
15 minutes after which excess stain was 
washed off under a running tap water and 
allowed to dry. A drop of immersion oil was 
then placed on the slide and viewed under 
the microscope using the X100 oil immer-
sion objective lens.The parasitemia was 
monitored in all the groups starting from 
day 5 to day 11 and estimated by examining 
a well of stained thin blood films made 
from the tail vein of the mice. This was ac-
complished by counting the number of 
pRBC seen in 104 RBC using the X100 oil 
immersion microscope. 
The % parasitemia was then calculated as 
follows  
 
%parasitemia=total number of pRBC X100 
   total number of RBC 
Estimation of % suppression para-
sitemiain mice 
The percentage suppression of parasitemia 
was calculated for each dose level by com-
paring the parasitemia in infected controls 
with those of treated mice as follows:  
% Suppression =   APN-APP 
                APN  
Where,  
APN= Average % parasitaemia in negative 
control  
APP= Aaverage % parasitaemia in positive 
groups  
APN= Average % parasitaemia in negative 
control 
 
Blood collection, Dissection and Collec-
tion of Organ 
At the end of the experiment, blood samples 
were collected from each surviving mice of 
the study by eye puncture method. The mice 
were gently held with the ventral side facing 
up by applying pressure on the dorsal skin 
fold close to the head region. The cornea of 
the eye was then punctured by means of a 
sterile capillary tube while the blood was col-
lected immediately into heparinised tubes. 
The sample bottles were gently rocked to 
allow a proper mixing of the blood with the 
anticoagulants in the sample bottles which 
were properly labelled. The animals were 
then sacrificed according to guides by 
Rowett (1977). The liver was then collected 
and stored in 10 % formalin for further his-
topathological studies. 
 
Haemathological Analysis of blood sam-
ples 
The Packed Cell Volume (PCV), 
Heamogloubin (Hb), Red blood cell (RBC), 
White blood cell (WBC), lymphocytes, neu-
trophil, monocyte and eosinophil were deter-




The biochemical parameters were deter-
mined using standard biochemical kit. Pa-
rameter assay includes Aspartate Amino 
Transferase (AST), Alanine Amino Transfer-
ase (ALT), Alkaline Phosphatase (ALP) and 
Gamma Glutamytanspeptidase (GGT) 
(Kutty and Jacob, 2004). 
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Histopathological studies 
The liver was collected from each sacrificed 
animal and stored in 10 % formalin in 
properly labelled sample bottles. The organs 
were thereafter dehydrated by passing them 
through increasing concentration of ethanol 
70 %, 80 %, 90 % and 100 % one hour each 
after the other to remove water from the 
tissues. Thereafter, the organ was impreg-
nated in three changes of molten wax to 
remove xylene from the tissue and to re-
place it with paraffin wax. The organs were 
later embedded in molten wax and allowed 
to solidify. The blocks were mounted on 
the microtome and sectioned at 5 microns. 
The histopathological analysis of the liver of 
animals was done using the method of 
(Morton et al., 1997). 
 
Data Analysis  
The results were expressed as mean ± SE. 
The data was analyzed using ANOVA and 
Duncan multiple range test, differences be-
tween mean were considered significant at 
(P< 0.05), using Statistical Package for So-




Results of the phytochemical screening of 
G. kola stem bark showed that it contained 
alkaloids, saponins, tannins, phenol, glyco-
sides, philobatannins and anthraquinones 
(Table 1). The iron content (38.45 %) of the 
plant was the highest of its mineral compo-
nents, followed by zinc (31.50 %), cupper 
(6.60 %) while calcium (0.04 %) and sodium 
(0.04 %) were the least (Table 2). The fibre 
(41.81 %) content of the plant sample was 
the highest, followed by moisture (9.96 %), 
protein (8.83 %) with fat (2.65 %) being the 
least (Table 3). In Figure 1, the mean body 
weight of all Plasmodium berghei infected mice 
decreased before and after treatment 
(Groups 1 - 5). A decrease in body weight 
was also observed in the groups treated with 
plant extract only (Group 6), whereas there 
was significant increase in the mean body 
weight of the control group (Group 7). The 
antiplasmodial effect of G. kola extract and 
chloroquine in mice is presented in Table 4. 
The extract significantly reduced PVC, Hb 
and RBC values in mice (Table 5). The treat-
ment ameliorated the adverse effect on bio-
chemical parameters of treated groups when 
compared to the untreated group (Table 6). 
Fig 2 shows the effect of the extract and 
standard drug on the liver of the mice.  
118 
`Phytochemical  Qualitative  
Alkaloids  +++ 
Saponins  +++ 
Tannins  ++ 
Phenols  +++ 
Glycosides  +++ 
Anthraquinones  ++ 
Table 1: Pytochemical components of Garcinia kola stembark 
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Mineral  Composition (%)  
Sodium  0.04+0.12e  
Potassium  0.11+ 0.12de  
Calcium  0.04+0.12de  
Phosphorus  0.22+0.12de  
Magnesium  0.30+0.05d    
Zinc  3.15+ 1.00b  
Cupper  0.66+1.00c  
Iron  3.84+1.00a  
Table 2: Mineral components of Garcinia kola stembark 
Values are mean ± SE, n = 2, Values having different superscript were considered  
significantly different  (P < 0.05) in quantity. 
Parameters  Composition (%)  
Protein  8.83±1.00b  
Fat  2.65±1.00e  
Ash  3.15±1.00d  
Fibre  41.81±1.00a  
Moisture  9.96±1.00b  
Table 3: Proximate contents of Garcinia kola stembark 
Legend: Values are mean ± SE, n = 2, Values having different superscript were considered signifi-
cantly (P < 0.05) different in quantity. 
J. Nat. Sci. Engr. & Tech. 2019, 18(1&2): 113-127 
Figure 1: Effect of treatment on mean body weight of the P. berghei infected and 
control mice.  
Group G1 (100 mg/kg of G. kola extract), Group G2 (200 mg/kg of G. kola extract), Group G3 (300 mg/kg of G. kola extract), Group 
G4 (5 mg/kg of chloroquine), Group G5 (infected but not treated), Group G6 (200 mg/kg of G. kola extract only), Group G7 (normal 
control). Day 0: Initial body weight before infection; Day1-7: Days of treatment after infection. 
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Group Parasitemia Count    Suppression 
(%)    Induction Day 1 Day 3 Day 5 Day 7 
G1 18.80±5.16*  17.92±4.47  6.56±2.16*  4.24±2.15  2.40±0.58*  33.60±2.95  20  
G2 19.92±1.37  19.28±6.28  5.44±1.97  3.00±0.59*  1.62±0.36*  95.18  20  
G3 18.68±1.75  8.02±3.38  3.86± 0.57  2.66±0.37*  1.60±0.38*  95.24  20  
G4 17.92±4.79  7.44±1.52*  5.12±1.26 3.00±0.27*  0.96±0.56*  97.14  20  
G5 15.16±1.37  17.92±4.46  22.70±0.75  31.20±3.42  33.60±2.95  0.0  80 
G6 - - - - - 0 - 
G7 - - - - - 0 - 
Mortality 
(%)   
Table 4: Suppressive effect of G. kola extract and chloroquine against P. berghei 
infection in mice 
Legend: Values are mean ± SE, n =5; *was considered significantly different compared 
with control group at P < 0.05.  
Chloroquine (CQ). Group G1 (100 mg/kg of G. kola extract), Group G2 (200 mg/kg of G. 
kola extract), Group G3 (300 mg/kg of G. kola extract), Group G4 (5 mg/kg of chloro-
quine), Group G5 (infected but not treated), Group G6 (200 mg/kg of G. kola extract on-

















































































































































Table 5: Effect of Garcinia kola extract and Chloroquine on the hematological  
parameters of P. berghei infected mice  
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Legend:  Values are mean ± SE, n = 5; Values having the different superscript were considered significantly different at P < 
0.05.  
Packed Cell Volume (PCV), HeamLgloubin (Hb), Red blood cell (RBC),White blood cell (WBC), Lymphocytes (Lymp), Neutro-
phil (Neutro), Monocyte (Mono), Eosinophil (Eosino), Chloroquine (CQ). Group G1 (100 mg/kg of G. kola extract), Group G2 
(200 mg/kg of G. kola extract), Group G3 (300 mg/kg of G. kola extract), Group G4 (5 mg/kg of chloroquine), Group G5 
(infected but not treated), Group G6 (200 mg/kg of G. kola extract only), Group G7 (normal control). 




AST (UI/L) ALT (UI/L) ALP (UI/L) BILIRUBIN 
(µmol/l) 
GGT(UI/L) 
G1 204.67±0.13ab 108.67±0.32b 135.67±0.24a 0.37±0.07ab 3.83±0.19a 
G2 170.00±0.13ab 130.00±0.05ab 153.00±0.24a 0.40±0.07ab 3.80±0.19a 
G3 144.50±0.13b 101.50±0.32b 120.50±0.24a 0.15±0.05b 3.00±0.19a 
G4 231.67±0.13a 125.67±0.23b 134.67±0.24a 0.27±0.05ab 3.80±0.19a 
G5 189.00±0.13ab 186.00±0.05a 154.33±0.24a 0.20±0.05ab 3.10±0.19a 
G6 194.33±0.13ab 130.67±0.05ab 130.67±0.24a 0.30±0.05ab 4.07±0.19a 
G7 206.00±0.13ab 116.33±0.32b 140.67±0.24a 0.40±0.07a 4.03±0.19a 
Table 6: Effect of extract of G. kola and chloroquine on the liver enzymes of  
P. berghei infected mice 
Legend: Values are mean ± SE, n = 5. Values having the different superscript from the 
control were considered significantly different at P-value < 0.05 
Chloroquine (CQ), Aspartate Amino Transferase (AST), Alanine Amino Transferase 
(ALT), Alkaline Phosphatase (ALP) Gamma Glutamytanspeptidase (GGT). Group G1 
(100 mg/kg of G. kola extract), Group G2 (200 mg/kg of G. kola extract), Group G3 (300 
mg/kg of G. kola extract), Group G4 (5 mg/kg of chloroquine), Group G5 (infected but 
not treated), Group G6 (200 mg/kg of G. kola extract only), Group G7 (normal control). 
J. Nat. Sci. Engr. & Tech. 2019, 18(1&2): 113-127 
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G1(100 mg/kg of G. kola): There was wide-
spread uniform severe vacuolar change of 
the hepatocytes.  
G2 (200 mg/kg of G. kola): There was 
moderate thinning of hepatic cords and 
multiple foci of Kupffer cells with intra-
cytoplasmic brownish yellow pigments. G3 
(300 mg/kg of G. kola): There was diffuse 
moderate vacuolar change of the hepato-
cytes. G4 (5 mg/kg chloroquine): There was 
moderate widespread thinning of hepatic 
cords and mild mononuclear perivascular 
cuffs. G5 (untreated mice): There was wide-
spread vacuolar change of the hepatocytes 
with increasing severity towards the peri-
portal areas; also mononuclear cellular ag-
gregates in the peri-portal areas. G6 (extract 
only 200 mg/kg): There was moderate vac-
uolar change of the hepatocytes.G7 
(control): The hepatocytes had a finely vacu-
olated (foamy) appearance (no visible lesion). 
 
DISCUSSION 
G. kola was rich in phytochemicals such as 
alkaloids, saponins, tannins, phenols and an-
thraquinones. The therapeutic activities of 
medicinal plants are attributed to their bioac-
tive components (Chindo et al., 2003). The 
literature is replete with information on an-
tiplasmodial activity of plant derived alka-
loids such as oxyacanthine, alstonerine, and 
cryptolepine (Saxena et al., 2003). In the pre-
sent study, the phytochemicals might be re-
sponsible for the antiplasmodial activity of 
G. kola stem bark. Furthermore, the mineral 
and nutritional components of the plant 
 122 
Figure 2: Histopathology of liver of control and treated groups of mice 
(Magnification x 400). 
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could serve as supplements to the phyto-
chemicals in their antiplasmodial activity. 
 
A decrease in body weight was observed in 
all infected groups. The decrease in body 
weight might be due to decrease in food 
intake owing to loss of appetite caused by 
malaria. The loss in body weight could be as 
a result of disturbed metabolic function and 
hypoglycaemia that are reportedly associat-
ed with malaria infection (WHO, 2011). 
The group that was treated with plant ex-
tract (200mg/kg) only also had a decrease in 
weight compared to the control group. This 
is an indication that G. kola stem bark could 
be valuable in the management of obesity. 
The finding of the present study agrees with 
an earlier report on decrease in body mass 
in rats fed with G. kola (Uko et al., 2001). 
The weight loss effect of the plant could be 
attributed to its high fibre content. Dietary 
fibres are employed in the treatment of dis-
eases such as obesity, diabetes, cancer and 
gastrointestinal disorders (Saldanha, 1995). 
 
The methanol extract of G. kola showed 
anti-plasmodial activity against P. berghei in-
fected mice based on percentage of parasite 
inhibition (94.55 - 95.24 %), the % parasite 
inhibition was in the order: Group 4 (97.14 
%) > Group 3 (95.24 %) > Group 2 (95.18 
%) > Group 1 (94.55 %). The chloroquine 
(5mg/kg) treated group (Group 4) was the 
most effective and 300mg/kg of extract 
(Group 3) was the most active treatment. 
The result of the antiplasmodial activity of 
G. kola stem bark recorded in this study evi-
denced by the significant suppression of 
parasitemia in the extract treated groups is 
in line with the reports of previous authors 
(Valsaraj et al., 1995). The observation is a 
further validation of the traditional use of 
the plant as herbal remedy for the treatment 
of malaria in Nigeria. 
 
In the present study, a marked reduction in 
the RBC, PVC and Hb was observed in un-
treated plasmodium infected rats, however, 
rats tested with methanol extract of G. kola 
stem bark showed dose dependent increase 
of these parameters. Anaemia is usually as-
sessed by evaluating PCV, Hb and RBC 
counts and previous authors have reported a 
progressive fall in RBC, PCV and Hb values 
in plasmodium infections (Ajagbonna et al., 
2002). The increase in haematological pa-
rameters is an attestation to the haematopoi-
etic potentials G. kola stem bark. The slight 
increase in platelet count recorded in all P. 
berghei infected mice might be as a result of 
the short period of infection; it is possible 
that prolonged or repeated infections may 
lead to thrombocytopenia. White blood cells 
(WBCs), as well as other cells, are involved 
in the body's immune system and help to 
fight diseases. They are increased in normal 
situations such as exertion and pregnancy, 
and abnormally in situations such as loss of 
blood, cancer, and most infections. An in-
crease in WBCs has been demonstrated to be 
linked to severe malaria (Modiano et al., 
2001). 
 
There was no significant difference in AST, 
ALT, ALP, bilirubin and GGT activities in 
all treated groups compared to the control 
group. Liver cell damage is characterized by 
a rise in plasma enzymes of AST, ALT, ALP 
and GGT levels (Adaramoye et al., 2008). 
The values of the plasma enzymes indicated 
no liver damage in all the groups treated with 
various doses of G. kola extract and standard 
drug. This finding confirms that G. kola is 
not hepatotoxic. The rate of mortality ob-
served in the infected but untreated group 
(Group 5) was 80 %, this was observed from 
the sixth day after infection with P. berghei. 
Massive lost in the total number of normal 
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RBC in this model showed a characteristic 
of severe sign of anaemia which is one of 
the major clinical manifestations of severe 
malaria in human. The pathogenesis of se-
vere anaemia during malaria infection is 
complex and involves multiple processes 
relating to both the destruction and de-
creased production of erythrocytes 
(Menendez et al., 2000).  
 
The histological studies revealed that there 
was severe damage in the liver of the infect-
ed but untreated group (Group 5). The 
damage could be as a result of parasite life 
cycle during erythrocytic stages in the blood 
stream. At the early stage of the exoerythro-
cytic phase, a parasite infects the hepatocyte 
and multiplies asexually releasing merozo-
ites which rupture their host cells. The lib-
erated merozoites leave the liver and enter 
the blood stream where they infect the red 
blood cells (Siddiqi et al., 2002). The infect-
ed groups treated with plant extract 
(Groups1 to 3) showed a moderate wide-
spread thinning of the hepatic cords; wide-
spread vacuolar change of the hepatocyte 
and moderate vacuolar change of periportal 
hepatocytes. This may be due to the brief 
delay before parasite clearance, that is, the 
period before treatment. The uninfected 
group (G6) treated with plant extract only 
had a moderate thinning of the hepatic 
cords; and moderate vacuolar change of the 
hepatocytes. Garcinia kola has protective 
effect against a variety of experimental 
hepatotoxins (Akintonwa and Essien, 1990). 
This confirms that consumption of G. kola 
stem bark is not toxic to the liver which is 
the first organ susceptible to any injurious 
substance in case of toxicity. The control 
group (G7) had normal hepatocytes and a 
few foci of moderate aggregates of mono-
nuclear cells.  
 
CONCLUSION 
Garcinia kola stem bark showed considerable 
antiplasmodial activity against P. berghie in-
fected mice and was best at 300mg/kg with 
no toxic effect. Further studies should in-
clude purification of active components with 
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